Interest of Biofer ® Compound Used in Blédilait Follow on Milk in Infant With Latent Iron Deficiency
Status:
Suspended
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The primary purpose of the study is to demonstrate the superiority of Bledilait milk (Biofer®
2mg/100kcal) in comparison with ferrous sulphate supplemented milk (2 mg/100 kcal) in infants
(6 to 12 months) with latent iron deficiency by measuring serum ferritin value after 2 months
of consumption of studied milks.